Shanghai Pharmaceuticals (02607.HK): Clevidipine Emulsion Injection Approved for Production

Zhito Finance APP News: Shanghai Pharmaceuticals (02607.HK) has issued an announcement. Recently, Shanghai Pharmaceuticals Holding Co., Ltd. (hereinafter referred to as the "Company")'s subsidiary Shanghai Shangyao First Biochemical Pharmaceutical Co., Ltd. (hereinafter referred to as "Shangyao First Biochemical") received the Drug Registration Certificate (Certificate Nos.: 2026S03524, 2026S03525) issued by the National Medical Products Administration (hereinafter referred to as the "NMPA") for Clevidipine Emulsion Injection (hereinafter referred to as "the Drug"), and the Drug has been approved for production.